BACKGROUND: Signal transduction cascade of anesthetic-induced preconditioning has been extensively studied, yet many aspects of it remain unsolved. Here, we investigated the roles of reactive oxygen species (ROS) and mitochondrial uncoupling in cardiomyocyte preconditioning by two modern volatile anesthetics: desflurane and sevoflurane. METHODS: Adult rat ventricular cardiomyocytes were isolated enzymatically. The preconditioning potency of desflurane and sevoflurane was assessed in cell survival experiments by evaluating myocyte protection from the oxidative stress-induced cell death. ROS production and flavoprotein fluorescence, an indicator of flavoprotein oxidation and mitochondrial uncoupling, were monitored in real time by confocal microscopy. The functional aspect of enhanced ROS generation by the anesthetics was assessed in cell survival and confocal experiments using the ROS scavenger Trolox. RESULTS: Preconditioning of cardiomyocytes with desflurane or sevoflurane significantly decreased oxidative stress-induced cell death. That effect coincided with increased ROS production and increased flavoprotein oxidation detected during acute myocyte exposure to the anesthetics. Desflurane induced significantly greater ROS production and flavoprotein oxidation than sevoflurane. ROS scavenging with Trolox abrogated preconditioning potency of anesthetics and attenuated flavoprotein oxidation. CONCLUSION: Preconditioning with desflurane or sevoflurane protects isolated rat cardiomyocytes from oxidative stress-induced cell death. Scavenging of ROS abolishes the preconditioning effect of both anesthetics and attenuates anesthetic-induced mitochondrial uncoupling, suggesting a crucial role for ROS in anesthetic-induced preconditioning and implying that ROS act upstream of mitochondrial uncoupling. Desflurane exhibits greater effect on stimulation of ROS production and mitochondrial uncoupling than sevoflurane.
BACKGROUND: Signal transduction cascade of anesthetic-induced preconditioning has been extensively studied, yet many aspects of it remain unsolved. Here, we investigated the roles of reactive oxygen species (ROS) and mitochondrial uncoupling in cardiomyocyte preconditioning by two modern volatile anesthetics: desflurane and sevoflurane. METHODS: Adult rat ventricular cardiomyocytes were isolated enzymatically. The preconditioning potency of desflurane and sevoflurane was assessed in cell survival experiments by evaluating myocyte protection from the oxidative stress-induced cell death. ROS production and flavoprotein fluorescence, an indicator of flavoprotein oxidation and mitochondrial uncoupling, were monitored in real time by confocal microscopy. The functional aspect of enhanced ROS generation by the anesthetics was assessed in cell survival and confocal experiments using the ROS scavenger Trolox. RESULTS: Preconditioning of cardiomyocytes with desflurane or sevoflurane significantly decreased oxidative stress-induced cell death. That effect coincided with increased ROS production and increased flavoprotein oxidation detected during acute myocyte exposure to the anesthetics. Desflurane induced significantly greater ROS production and flavoprotein oxidation than sevoflurane. ROS scavenging with Trolox abrogated preconditioning potency of anesthetics and attenuated flavoprotein oxidation. CONCLUSION: Preconditioning with desflurane or sevoflurane protects isolated rat cardiomyocytes from oxidative stress-induced cell death. Scavenging of ROS abolishes the preconditioning effect of both anesthetics and attenuates anesthetic-induced mitochondrial uncoupling, suggesting a crucial role for ROS in anesthetic-induced preconditioning and implying that ROS act upstream of mitochondrial uncoupling. Desflurane exhibits greater effect on stimulation of ROS production and mitochondrial uncoupling than sevoflurane.
Authors: Hong Yan Zhang; Bradley C McPherson; Huiping Liu; Timir S Baman; Peter Rock; Zhenhai Yao Journal: Am J Physiol Heart Circ Physiol Date: 2002-04 Impact factor: 4.733
Authors: V Piriou; P Chiari; F Lhuillier; O Bastien; J Loufoua; O Raisky; J S David; M Ovize; J J Lehot Journal: Br J Anaesth Date: 2002-09 Impact factor: 9.166
Authors: T Pain; X M Yang; S D Critz; Y Yue; A Nakano; G S Liu; G Heusch; M V Cohen; J M Downey Journal: Circ Res Date: 2000-09-15 Impact factor: 17.367
Authors: Katsuya Tanaka; Dorothee Weihrauch; Franz Kehl; Lynda M Ludwig; John F LaDisa; Judy R Kersten; Paul S Pagel; David C Warltier Journal: Anesthesiology Date: 2002-12 Impact factor: 7.892
Authors: Leo G Kevin; Enis Novalija; Matthias L Riess; Amadou K S Camara; Samhita S Rhodes; David F Stowe Journal: Anesth Analg Date: 2003-04 Impact factor: 5.108
Authors: J P Sarkey; M Chu; M McShane; E Bovo; Y Ait Mou; A V Zima; P P de Tombe; G L Kartje; J L Martin Journal: J Mol Cell Cardiol Date: 2011-03-17 Impact factor: 5.000
Authors: Scott G Canfield; Ana Sepac; Filip Sedlic; Maria Y Muravyeva; Xiaowen Bai; Zeljko J Bosnjak Journal: Anesthesiology Date: 2012-10 Impact factor: 7.892
Authors: Naoyuki Hirata; Yon Hee Shim; Danijel Pravdic; Nicole L Lohr; Philip F Pratt; Dorothee Weihrauch; Judy R Kersten; David C Warltier; Zeljko J Bosnjak; Martin Bienengraeber Journal: Anesthesiology Date: 2011-09 Impact factor: 7.892
Authors: Filip Sedlic; Maria Y Muravyeva; Ana Sepac; Marija Sedlic; Anna Marie Williams; Meiying Yang; Xiaowen Bai; Zeljko J Bosnjak Journal: J Cell Physiol Date: 2016-06-21 Impact factor: 6.384
Authors: Saban Yalcin; Harun Aydoğan; Hasan Husnu Yuce; Ahmet Kucuk; Mahmut Alp Karahan; Mehmet Vural; Aysun Camuzcuoğlu; Nurten Aksoy Journal: Wien Klin Wochenschr Date: 2013-07-17 Impact factor: 1.704